Market Cap : 8.51 B | Enterprise Value : 8.34 B | P/E (TTM) : | P/B : 50.06 |
---|
NAS:BBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2021-01-19), BridgeBio Pharma's share price is $69.380000. BridgeBio Pharma's Tangible Book per Share of Sep. 2020 for the quarter that ended in Sep. 2020 was $1.39. Hence, BridgeBio Pharma's Price to Tangible Book Ratio of today is 50.06.
During the past 3 years, BridgeBio Pharma's highest Price to Tangible Book Ratio was 49.91. The lowest was 5.48. And the median was 10.61.
A closely related ratio is called PB Ratio. As of today, BridgeBio Pharma's share price is $69.380000. BridgeBio Pharma's Book Value per Sharefor the quarter that ended in Sep. 2020 was $1.39. Hence, BridgeBio Pharma's P/B Ratio of today is 50.06.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where BridgeBio Pharma's Price-to-Tangible-Book falls into.
BridgeBio Pharma's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Sep. 2020 ) |
= | 69.380000 | / | 1.386 | |
= | 50.06 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
No Headline